Idiopathic Short Stature Therapeutics Pipeline Review, H1 2015 offers “Idiopathic Short Stature – Pipeline Review, H1 2015”global research report on its store.

This report provides comprehensive information on the therapeutic development for Idiopathic Short Stature, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Idiopathic Short Stature and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Complete report is available at .

Scope of The Report:

  • The report provides a snapshot of the global therapeutic landscape of Idiopathic Short Stature
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Idiopathic Short Stature and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Idiopathic Short Stature products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Idiopathic Short Stature pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to Buy This Report:

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Idiopathic Short Stature
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Idiopathic Short Stature pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Order a copy of this report at .

Table of Content for “Idiopathic Short Stature – Pipeline Review, H1 2015” research report includes:

Idiopathic Short Stature Overview 6

Therapeutics Development 7

Pipeline Products for Idiopathic Short Stature - Overview 7

Pipeline Products for Idiopathic Short Stature - Comparative Analysis 8

Idiopathic Short Stature - Therapeutics under Development by Companies 9

Idiopathic Short Stature - Pipeline Products Glance 10

Late Stage Products 10

Clinical Stage Products 11

Early Stage Products 12

Idiopathic Short Stature - Products under Development by Companies 13

Idiopathic Short Stature - Companies Involved in Therapeutics Development 14

Bolder Biotechnology, Inc. 14

Braasch Biotech LLC 15

Dong-A Socio Group 16

LG Life Sciences, Ltd. 17

Myungmoon pharmaceutical Co.,Ltd. 18

Idiopathic Short Stature - Therapeutics Assessment 19

Assessment by Monotherapy Products 19

Assessment by Target 20

Assessment by Mechanism of Action 22

Assessment by Route of Administration 23

Assessment by Molecule Type 24

Drug Profiles 26

BBT-031 - Drug Profile 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

MM-P02-01 - Drug Profile 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

somatropin - Drug Profile 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

somatropin SR - Drug Profile 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Vaccine for Growth Hormone Deficiencies - Drug Profile 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Idiopathic Short Stature - Recent Pipeline Updates 32

Idiopathic Short Stature - Dormant Projects 33

Idiopathic Short Stature - Discontinued Products 34

Priced at US $2000  for a single user PDF, a discount on this research report can be requested at .

About Us:

RnR Market Research library offers syndicated reports by market research publishers from across the globe. We help you find the most relevant business intelligence from ready-to-buy syndicated market research studies. Not limited to industry reports covering telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, F&B , media and more, RnR Market Research also offers company data, country profiles, trends, information and analysis on the sector of your interest. ( ).